Nutri Pharmaceuticals Research, Inc.
NRPR
$0.021
$0.005535.48%
12/31/2003 | |||||
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 90.10K | ||||
Total Receivables | 125.00K | ||||
Inventory | 259.10K | ||||
Prepaid Expenses | -- | ||||
Finance Division Loans and Leases Current | -- | ||||
Total Finance Division Other Current Assets | -- | ||||
Other Current Assets | -- | ||||
Total Current Assets | 474.10K | ||||
|
|||||
Total Current Assets | 474.10K | ||||
Net Property, Plant & Equipment | 197.30K | ||||
Long-term Investments | -- | ||||
Goodwill | -- | ||||
Total Other Intangibles | -- | ||||
Finance Div Loans & Leases LT | -- | ||||
Total Finance Div Other LT Assets | -- | ||||
Total Other Assets | 4.50K | ||||
Total Assets | 676.00K | ||||
|
|||||
Total Accounts Payable | 192.60K | ||||
Total Accrued Expenses | 48.70K | ||||
Short-term Debt | 83.60K | ||||
Current Portion of Long-Term Debt/Capital Leases | -- | ||||
Finance Division Debt Current | 42.30K | ||||
Total Finance Division Other Current Liabilities | 70.40K | ||||
Total Other Current Liabilities | 70.40K | ||||
Total Current Liabilities | 437.60K | ||||
|
|||||
Total Current Liabilities | 437.60K | ||||
Long-Term Debt | -- | ||||
Short-term Debt | 83.60K | ||||
Capital Leases | -- | ||||
Finance Division Debt Non Current | -- | ||||
Total Finance Division Other Non Current Liabilities | -- | ||||
Total Other Liabilities | -- | ||||
Total Liabilities | 437.60K | ||||
|
|||||
Common Stock & APIC | 548.80K | ||||
Retained Earnings | -188.20K | ||||
Treasury Stock & Other | -122.20K | ||||
Total Common Equity | 238.40K | ||||
|
|||||
Preferred Stock Redeemable | -- | ||||
Preferred Stock Non Redeemable | -- | ||||
Preferred Stock Convertible | -- | ||||
Preferred Stock, Others | -- | ||||
Total Preferred Equity | -- | ||||
|
|||||
Total Common Equity | 238.40K | ||||
Total Preferred Equity | -- | ||||
Total Minority Interest | -- | ||||
Total Equity | 238.40K | ||||
|